Bonnie L. Bassler - 26 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
26 Feb 2024
Net transactions value
-$501,580
Form type
4
Filing time
26 Feb 2024, 16:07:53 UTC
Previous filing
31 Jan 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $334,700 +854 +62% $391.92 2,236 26 Feb 2024 Direct
transaction REGN Common Stock Sale $836,280 -854 -38% $979.25 1,382 26 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -854 -100% $0.000000* 0 26 Feb 2024 Common Stock 854 $391.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.